First Time Loading...
C

Codex DNA Inc
NASDAQ:DNAY

Watchlist Manager
Codex DNA Inc
NASDAQ:DNAY
Watchlist
Price: 2 USD 8.11% Market Closed
Updated: May 4, 2024
DNAY
/
Income Statement
/
Revenue

Codex DNA Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Codex DNA Inc
Revenue Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
C
Codex DNA Inc
NASDAQ:DNAY
Revenue
$27.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Revenue
$42.9B
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
13%
Danaher Corp
NYSE:DHR
Revenue
$43.7B
CAGR 3-Years
21%
CAGR 5-Years
21%
CAGR 10-Years
9%
Mettler-Toledo International Inc
NYSE:MTD
Revenue
$3.8B
CAGR 3-Years
7%
CAGR 5-Years
5%
CAGR 10-Years
5%
Agilent Technologies Inc
NYSE:A
Revenue
$6.7B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
8%
IQVIA Holdings Inc
NYSE:IQV
Revenue
$15B
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
11%

Codex DNA Inc
Revenue Breakdown

Breakdown by Geography
Codex DNA Inc

Not Available

Breakdown by Segments
Codex DNA Inc

Total Revenue: 27.4m USD
100%
Product: 10.9m USD
39.8%
Service: 7.1m USD
26%
Collaboration Revenue: 6.7m USD
24.2%
Royalties And Other Revenue: 2.8m USD
10%
Show More
Show Less

See Also

What is Codex DNA Inc's Revenue?
Revenue
27.4m USD

Based on the financial report for Dec 31, 2022, Codex DNA Inc's Revenue amounts to 27.4m USD.

What is Codex DNA Inc's Revenue growth rate?
Revenue CAGR 1Y
148%

Over the last year, the Revenue growth was 148%.

ALPHA SPREAD
Join more than 134,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.